HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Shah, S. S. Articles by Goldstraw, P. Search for Related Content PubMed PubMed Citation Articles by Shah, S. S. Articles by Goldstraw, P.

The Annals of Thoracic Surgery, Vol 54, 498-501, Copyright © 1992 by The Society of Thoracic Surgeons

ARTICLES

Results of operation without adjuvant therapy in the treatment of small cell lung cancer

SS Shah, J Thompson and P Goldstraw
Department of Thoracic Surgery, Royal Brompton National Heart & Lung Hospitals, London, England.

The role of surgery in the treatment of small cell lung cancer remains a subject of debate. We carried out a retrospective review of 87 patients with small cell lung cancer referred to one surgeon for staging and treatment. Thirty patients (34.5%) were deemed suitable for thoracotomy. Fourteen patients had stage I disease, 5 patients had stage II disease, and 11 patients had stage III disease. Twenty-eight of the 30 patients (93.3%) went on to have surgical resection. The actual overall 5-year survival in all patients who underwent thoracotomy was 43.3%. The actual 5-year survival for patients in stages I and III was 57.1% and 55.5%, respectively. No patients with stage II disease survived 5 years. We conclude that there is a small group of patients with small cell lung cancer in whom, with careful preoperative staging, the prospects of cure by operation are similar to those with non-small lung cancer.

This article has been cited by other articles:

				A. Granetzny, A. Boseila, W. Wagner, G. Krukemeyer, U. Vogt, E. Hecker, O. M. Koch, and F. Klinke Surgery in the tri-modality treatment of small cell lung cancer. Stage-dependent survival. Eur. J. Cardiothorac. Surg., August 1, 2006; 30(2): 212 - 216. [Abstract] [Full Text] [PDF]

				R. Tsuchiya, K. Suzuki, Y. Ichinose, Y. Watanabe, T. Yasumitsu, N. Ishizuka, and H. Kato Phase II trial of postoperative adjuvant cisplatin and etoposide in patients with completely resected stage I-IIIa small cell lung cancer: The Japan Clinical Oncology Lung Cancer Study Group Trial (JCOG9101) J. Thorac. Cardiovasc. Surg., May 1, 2005; 129(5): 977 - 983. [Abstract] [Full Text] [PDF]

				R. Kumar, Y. Xiu, J. Q. Yu, A. Takalkar, G. El-Haddad, S. Potenta, J. Kung, H. Zhuang, and A. Alavi 18F-FDG PET in Evaluation of Adrenal Lesions in Patients with Lung Cancer J. Nucl. Med., December 1, 2004; 45(12): 2058 - 2062. [Abstract] [Full Text] [PDF]

				T. Lewinski, M. Zulawski, C. Turski, and A. Pietraszek Small cell lung cancer I-III A: cytoreductive chemotherapy followed by resection with continuation of chemotherapy Eur. J. Cardiothorac. Surg., August 1, 2001; 20(2): 391 - 398. [Abstract] [Full Text] [PDF]

				R. J. Ginsberg Small cell lung cancer: how should we treat it? what is it? Ann. Thorac. Surg., November 1, 2000; 70(5): 1453 - 1454. [Full Text] [PDF]